NO325836B1 - Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav - Google Patents

Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav Download PDF

Info

Publication number: NO325836B1
Authority: NO; Norway
Prior art keywords: peptide; blood; amino acid; triglyceride levels; levels
Prior art date: 1996-03-22

Application number

NO19975360A

Other languages

English (en)

Norwegian (no)

Other versions

NO975360L (no

NO975360D0 (no

Inventor

Kyoichi Kagawa

Hisako Matsutaka

Chizuko Fukuhama

Hiroaki Fujino

Masahiro Numata

Kazuhisa Honda

Toyoo Nakamura

Original Assignee

Mg Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-22

Filing date

1997-11-21

Publication date

2008-07-28

1997-11-21 Application filed by Mg Pharma Inc filed Critical Mg Pharma Inc

1997-11-21 Publication of NO975360D0 publication Critical patent/NO975360D0/no

1998-01-21 Publication of NO975360L publication Critical patent/NO975360L/no

2008-07-28 Publication of NO325836B1 publication Critical patent/NO325836B1/no

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 106
210000004369 blood Anatomy 0.000 title claims abstract description 53
239000008280 blood Substances 0.000 title claims abstract description 53
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title claims abstract description 25
230000002401 inhibitory effect Effects 0.000 claims abstract description 36
239000003795 chemical substances by application Substances 0.000 claims abstract description 28
235000013305 food Nutrition 0.000 claims abstract description 17
208000008589 Obesity Diseases 0.000 claims abstract description 11
235000020824 obesity Nutrition 0.000 claims abstract description 11
201000005577 familial hyperlipidemia Diseases 0.000 claims abstract description 8
230000036541 health Effects 0.000 claims abstract description 6
125000003275 alpha amino acid group Chemical group 0.000 claims abstract 8
238000002360 preparation method Methods 0.000 claims description 17
238000004519 manufacturing process Methods 0.000 claims description 8
241000251468 Actinopterygii Species 0.000 abstract description 14
241001465754 Metazoa Species 0.000 abstract description 11
239000000463 material Substances 0.000 abstract description 9
235000013372 meat Nutrition 0.000 abstract description 6
206010003210 Arteriosclerosis Diseases 0.000 abstract description 5
208000011775 arteriosclerosis disease Diseases 0.000 abstract description 5
244000144972 livestock Species 0.000 abstract description 5
206010020772 Hypertension Diseases 0.000 abstract description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
235000013376 functional food Nutrition 0.000 abstract description 4
108010072695 valyl-valyl-tyrosyl-proline Proteins 0.000 abstract description 3
201000010099 disease Diseases 0.000 abstract description 2
150000001413 amino acids Chemical group 0.000 description 33
238000000034 method Methods 0.000 description 31
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
102000018146 globin Human genes 0.000 description 19
108060003196 globin Proteins 0.000 description 19
239000003531 protein hydrolysate Substances 0.000 description 19
239000012071 phase Substances 0.000 description 18
230000000694 effects Effects 0.000 description 16
239000000243 solution Substances 0.000 description 16
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
229940024606 amino acid Drugs 0.000 description 15
108090000623 proteins and genes Proteins 0.000 description 14
LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 12
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 11
235000018102 proteins Nutrition 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
PMKQKNBISAOSRI-XHSDSOJGSA-N Val-Tyr-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N PMKQKNBISAOSRI-XHSDSOJGSA-N 0.000 description 10
102000004196 processed proteins & peptides Human genes 0.000 description 10
238000000108 ultra-filtration Methods 0.000 description 10
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
239000002243 precursor Substances 0.000 description 8
239000011347 resin Substances 0.000 description 8
229920005989 resin Polymers 0.000 description 8
230000002378 acidificating effect Effects 0.000 description 7
238000004587 chromatography analysis Methods 0.000 description 7
210000004051 gastric juice Anatomy 0.000 description 7
230000005764 inhibitory process Effects 0.000 description 7
238000010521 absorption reaction Methods 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
230000029087 digestion Effects 0.000 description 6
238000005342 ion exchange Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
230000007935 neutral effect Effects 0.000 description 6
239000000843 powder Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
230000037396 body weight Effects 0.000 description 5
235000019219 chocolate Nutrition 0.000 description 5
239000007788 liquid Substances 0.000 description 5
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 5
238000004366 reverse phase liquid chromatography Methods 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
241000283690 Bos taurus Species 0.000 description 4
238000005903 acid hydrolysis reaction Methods 0.000 description 4
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
238000001514 detection method Methods 0.000 description 4
239000012530 fluid Substances 0.000 description 4
235000013336 milk Nutrition 0.000 description 4
239000008267 milk Substances 0.000 description 4
210000004080 milk Anatomy 0.000 description 4
230000008569 process Effects 0.000 description 4
238000000926 separation method Methods 0.000 description 4
239000012086 standard solution Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
102000001554 Hemoglobins Human genes 0.000 description 3
108010054147 Hemoglobins Proteins 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
108010038807 Oligopeptides Proteins 0.000 description 3
102000015636 Oligopeptides Human genes 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000007979 citrate buffer Substances 0.000 description 3
102000038379 digestive enzymes Human genes 0.000 description 3
108091007734 digestive enzymes Proteins 0.000 description 3
239000003814 drug Substances 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000010647 peptide synthesis reaction Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
238000000746 purification Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
-1 t-butoxycarbonyl group Chemical group 0.000 description 3
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
108091005508 Acid proteases Proteins 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
208000031226 Hyperlipidaemia Diseases 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
241000282887 Suidae Species 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
150000008065 acid anhydrides Chemical class 0.000 description 2
230000037005 anaesthesia Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
239000000872 buffer Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
238000010411 cooking Methods 0.000 description 2
235000020805 dietary restrictions Nutrition 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
210000002196 fr. b Anatomy 0.000 description 2
210000000540 fraction c Anatomy 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
238000001641 gel filtration chromatography Methods 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
230000037356 lipid metabolism Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
235000020845 low-calorie diet Nutrition 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
229940105631 nembutal Drugs 0.000 description 2
239000004006 olive oil Substances 0.000 description 2
235000008390 olive oil Nutrition 0.000 description 2
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
239000002994 raw material Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
238000007789 sealing Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
210000001631 vena cava inferior Anatomy 0.000 description 2
235000020852 very low calorie diet Nutrition 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
ZQEBQGAAWMOMAI-ZETCQYMHSA-N (2s)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC[C@H]1C(O)=O ZQEBQGAAWMOMAI-ZETCQYMHSA-N 0.000 description 1
CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 1
SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 1
BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
241000228245 Aspergillus niger Species 0.000 description 1
108091005658 Basic proteases Proteins 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004129 EU approved improving agent Substances 0.000 description 1
241000283086 Equidae Species 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
206010018910 Haemolysis Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
102000004157 Hydrolases Human genes 0.000 description 1
108090000604 Hydrolases Proteins 0.000 description 1
239000005909 Kieselgur Substances 0.000 description 1
239000004395 L-leucine Substances 0.000 description 1
235000019454 L-leucine Nutrition 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
108010070551 Meat Proteins Proteins 0.000 description 1
102000036675 Myoglobin Human genes 0.000 description 1
108010062374 Myoglobin Proteins 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
108091005507 Neutral proteases Proteins 0.000 description 1
102000035092 Neutral proteases Human genes 0.000 description 1
VRAHPESAMYMDQI-UHFFFAOYSA-N Nicomol Chemical compound C1CCC(COC(=O)C=2C=NC=CC=2)(COC(=O)C=2C=NC=CC=2)C(O)C1(COC(=O)C=1C=NC=CC=1)COC(=O)C1=CC=CN=C1 VRAHPESAMYMDQI-UHFFFAOYSA-N 0.000 description 1
108010019160 Pancreatin Proteins 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108010064851 Plant Proteins Proteins 0.000 description 1
TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
244000184734 Pyrus japonica Species 0.000 description 1
241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
101150021948 SAM2 gene Proteins 0.000 description 1
241000276699 Seriola Species 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
108010073771 Soybean Proteins Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
229920002494 Zein Polymers 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
125000005042 acyloxymethyl group Chemical group 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
239000000920 calcium hydroxide Substances 0.000 description 1
229910001861 calcium hydroxide Inorganic materials 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003729 cation exchange resin Substances 0.000 description 1
229920001429 chelating resin Polymers 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
229960001214 clofibrate Drugs 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
235000021438 curry Nutrition 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
235000013373 food additive Nutrition 0.000 description 1
239000002778 food additive Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000004459 forage Substances 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
235000013350 formula milk Nutrition 0.000 description 1
210000003918 fraction a Anatomy 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
239000008187 granular material Substances 0.000 description 1
235000013402 health food Nutrition 0.000 description 1
230000008588 hemolysis Effects 0.000 description 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
229960003136 leucine Drugs 0.000 description 1
235000019626 lipase activity Nutrition 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000011259 mixed solution Substances 0.000 description 1
230000003020 moisturizing effect Effects 0.000 description 1
210000003550 mucous cell Anatomy 0.000 description 1
229950001071 nicomol Drugs 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
230000033116 oxidation-reduction process Effects 0.000 description 1
229940055695 pancreatin Drugs 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
235000021118 plant-derived protein Nutrition 0.000 description 1
TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
229960002965 pravastatin Drugs 0.000 description 1
230000002265 prevention Effects 0.000 description 1
235000011962 puddings Nutrition 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
235000015067 sauces Nutrition 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
235000019710 soybean protein Nutrition 0.000 description 1
238000013112 stability test Methods 0.000 description 1
235000013547 stew Nutrition 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
239000003826 tablet Substances 0.000 description 1
231100000041 toxicology testing Toxicity 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000003643 water by type Substances 0.000 description 1
239000005019 zein Substances 0.000 description 1
229940093612 zein Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Animal Husbandry (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Zoology (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Peptides Or Proteins (AREA)
Fodder In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO19975360A 1996-03-22 1997-11-21 Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav NO325836B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP8066916A JP2805194B2 (ja)	1996-03-22	1996-03-22	血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
PCT/JP1996/001570 WO1997035875A1 (en)	1996-03-22	1996-06-10	Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient

Publications (3)

Publication Number	Publication Date
NO975360D0 NO975360D0 (no)	1997-11-21
NO975360L NO975360L (no)	1998-01-21
NO325836B1 true NO325836B1 (no)	2008-07-28

Family

ID=13329785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19975360A NO325836B1 (no)	1996-03-22	1997-11-21	Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav

Country Status (11)

Country	Link
US (1)	US5958885A (ja)
EP (1)	EP0838473B1 (ja)
JP (1)	JP2805194B2 (ja)
KR (1)	KR100264344B1 (ja)
AT (1)	ATE225803T1 (ja)
AU (1)	AU690853B2 (ja)
CA (1)	CA2221767C (ja)
DK (1)	DK0838473T3 (ja)
ES (1)	ES2184865T3 (ja)
NO (1)	NO325836B1 (ja)
WO (1)	WO1997035875A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000095794A (ja) *	1998-09-22	2000-04-04	Itoham Foods Inc	エンケファリン分解酵素の阻害剤
JP2000264845A (ja) *	1999-02-04	2000-09-26	Nippon Synthetic Chem Ind Co Ltd:The	コレステロール降下剤及びその用途
AU2001281464A1 (en) *	2000-03-13	2001-09-24	Monsanto Technology Llc	Recombinant proteins containing repeating units
DE10105041A1 (de) *	2001-02-05	2002-08-14	Tell Pharm Ag Hergiswil	Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US20070254889A1 (en) *	2001-04-23	2007-11-01	Lee-Way Jin	Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease
AU2003225277A1 (en) *	2002-05-02	2003-11-17	Robert Harris	Lipid removal from the body
GB0211849D0 (en) *	2002-05-23	2002-07-03	Mok Kenneth H	Improvments to retro-inverso isomers
NO322425B1 (no) *	2003-07-04	2006-10-02	Berge Biomed As	Anvendelse av et hydrolysat av proteinholdig fiskemateriale for fremstilling av et farmasoytisk middel for behandling og/eller hindring av patologisk hoye nivaer av tracylglyceroler, hyperkolesterolemia, hyperhomocysteinemia, eller patologisk lave nivaer av beta-oksidasjon i et dyr eller menneske.
US20080063781A1 (en) *	2004-09-30	2008-03-13	Suntory Limited	Globin Digest Containing, Yeast-Fermented Beverages
DK1824501T3 (da) *	2004-11-15	2009-12-21	Mg Pharma Inc	Proteinhydrolysat med antidiabetisk virkning
JP4395658B2 (ja) *	2005-11-17	2010-01-13	エムジーファーマ株式会社	コレステロール再上昇抑制用組成物およびその用法
JP5175484B2 (ja) *	2007-03-30	2013-04-03	名古屋製酪株式会社	血中中性脂肪濃度上昇抑制剤
CN101815525B (zh) *	2007-08-07	2013-05-29	爱沐健制药株式会社	降血压剂
CN107551258B (zh) *	2016-06-30	2021-01-05	江西本草天工科技有限责任公司	用于预防和/或治疗肝损伤的vvyp
WO2018001273A1 (zh) *	2016-06-30	2018-01-04	江西本草天工科技有限责任公司	肽或其盐、其制备方法、及其制备预防和/或治疗肝损伤药物的用途
CN107556363B (zh) *	2016-06-30	2021-03-30	江西本草天工科技有限责任公司	肽或其盐及其制备方法
JP6832992B2 (ja) *	2018-09-12	2021-02-24	エムジーファーマ株式会社	抗肥満用組成物
JP2024102740A (ja) *	2023-01-19	2024-07-31	ロート製薬株式会社	疲労軽減又は疲労回復促進用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1335567C (en) *	1988-02-02	1995-05-16	Kyoichi Kagawa	Lipid metabolism promoting agent
US5723443A (en) *	1988-02-02	1998-03-03	Hankyu-Kyoei Bussan Co. Ltd.	Lipid metabolism promoting agent and its use
JP2764276B2 (ja) *	1988-09-06	1998-06-11	仙味エキス株式会社	機能性新規ペプチド及びその利用
JPH0331298A (ja) *	1989-06-28	1991-02-12	Ajinomoto Co Inc	プロリルエンドペプチターゼ阻害ペプチド
JPH03120224A (ja) *	1989-10-04	1991-05-22	Ajinomoto Co Inc	新規ペプチドおよびこれを含有する降圧剤
JP3312944B2 (ja) *	1993-03-24	2002-08-12	伊藤ハム株式会社	脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤
JP2800877B2 (ja) *	1993-12-28	1998-09-21	伊藤ハム株式会社	血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤

1996
- 1996-03-22 JP JP8066916A patent/JP2805194B2/ja not_active Expired - Lifetime
- 1996-06-10 EP EP96916354A patent/EP0838473B1/en not_active Expired - Lifetime
- 1996-06-10 ES ES96916354T patent/ES2184865T3/es not_active Expired - Lifetime
- 1996-06-10 AT AT96916354T patent/ATE225803T1/de not_active IP Right Cessation
- 1996-06-10 KR KR1019970708355A patent/KR100264344B1/ko not_active Expired - Lifetime
- 1996-06-10 WO PCT/JP1996/001570 patent/WO1997035875A1/ja not_active Ceased
- 1996-06-10 CA CA002221767A patent/CA2221767C/en not_active Expired - Fee Related
- 1996-06-10 US US08/973,539 patent/US5958885A/en not_active Expired - Lifetime
- 1996-06-10 DK DK96916354T patent/DK0838473T3/da active
- 1996-06-10 AU AU59120/96A patent/AU690853B2/en not_active Ceased
1997
- 1997-11-21 NO NO19975360A patent/NO325836B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0838473B1 (en)	2002-10-09
DK0838473T3 (da)	2003-02-17
KR19990021880A (ko)	1999-03-25
NO975360L (no)	1998-01-21
JP2805194B2 (ja)	1998-09-30
ATE225803T1 (de)	2002-10-15
EP0838473A1 (en)	1998-04-29
EP0838473A4 (en)	2000-04-05
CA2221767A1 (en)	1997-10-02
US5958885A (en)	1999-09-28
NO975360D0 (no)	1997-11-21
JPH09255698A (ja)	1997-09-30
ES2184865T3 (es)	2003-04-16
AU690853B2 (en)	1998-04-30
CA2221767C (en)	2001-01-23
WO1997035875A1 (en)	1997-10-02
AU5912096A (en)	1997-10-17
KR100264344B1 (ko)	2000-08-16

Legal Events

Date	Code	Title	Description
2012-01-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO325836B1 (no)	2008-07-28	Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav
EP0753526B1 (en)	2000-12-20	Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
Netto et al.	1998	Production and characterization of enzymatic hydrolysate from soy protein isolate
JPH05276896A (ja)	1993-10-26	高フィッシャー比ペプチド混合物、その製造法、および肝疾患患者用栄養補給組成物
US6046168A (en)	2000-04-04	Peptide inhibits blood triglyceride level
US20150183822A1 (en)	2015-07-02	Angiotensin-converting-enzyme inhibiting dipeptide
KR100960843B1 (ko)	2010-06-07	신규 펩타이드 ｓｙ
JP2800877B2 (ja)	1998-09-21	血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
EP1930017B1 (en)	2012-05-23	Composition effective for prevention and treatment of adult disease
AU714225B2 (en)	1999-12-23	Agents for inhibiting accumulation of visceral fat
AU708938B2 (en)	1999-08-19	A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component
US5444046A (en)	1995-08-22	Amylase inhibitors
US6767990B1 (en)	2004-07-27	Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof
CA2225412C (en)	2001-02-20	A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component
NO318683B1 (no)	2005-04-25	Peptidblanding og middel som inhiberer okning av triglyceridniva i blod, samt matvare og fôr som omfatter peptidblandingen.
KR100600578B1 (ko)	2006-07-13	가자미 프레임으로부터 분리한 가수분해물 및 이를함유하는 항고혈압 조성물
JP3733376B2 (ja)	2006-01-11	ペプチド並びにそれを含有するプロリルエンドペプチダーゼ阻害剤、機能性食品及び動物用飼料
HK1136586A1 (en)	2010-07-02	Collagen peptide composition and food or beverage containing the same
HK1136586B (en)	2014-08-08	Collagen peptide composition and food or beverage containing the same